Celon Pharma S.A.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2012-10-25
Share capital
5,385,650.00 PLN
Activity description

Celon Pharma is an integrated pharmaceutical company conducting advanced scientific research and manufacturing modern medicines. The company also markets its own pharmaceutical products.

Registered address
Ogrodowa 2A, 05-092 Kiełpin, Poland
Email
Electronic delivery address
AE:PL-58206-76240-RVIES-16

Financials

Revenue history (in m)

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 127 days for 2024). All were audited by a statutory auditor.

  • 202522/09/2026
  • 202419/11/2025
  • 202305/07/2024
  • 202202/10/2023
  • 202128/06/2022
  • 202016/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Stock quotes

PLN 15.40
-0.40 (-2.53%)
15.2015.4015.6015.8015.4010:0012:0014:0016:00
Open
PLN 15.80
High
PLN 15.86
Low
PLN 15.20
Volume
34.15K
Avg. vol.
32.6K
Market cap
PLN 832.39M
P/E ratio
7.53
EPS
PLN 2.05
Shares outstanding
53.91M
52-week
PLN 15.20 – 17.72
Dividend yield
0.52%
Dividend
PLN 0.08
Ex dividend date
Jun 27, 2024
Exchange
GPW Main Market

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD 16.23mUSD -2.56mUSD -8.26m
Q1 2026USD 16.71mUSD -1.61mUSD 43.92m
Q4 2025USD 16.16mUSD 634.61kUSD -6.25m
Q3 2025USD 18.60mUSD 2.02mUSD 919.89k

Results for Q3 2026:Nov 18, 2026

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Top 9.7%
Sector · Manufacturing1,421 / 33,822
Top 4.2%
Voivodeship · Mazowieckie1,892 / 142,204
Top 1.3%
Country · Poland5,547 / 496,474
Top 1.1%

Results vs industry

Revenue
This companyUSD 51.77mMedianUSD 913.43kAverageUSD 25.82m
Net profit
This companyUSD -8.63mMedianUSD 14.22kAverageUSD 2.77m
Operating costs
This companyUSD 65.26mMedianUSD 846.99kAverageUSD 21.42m
Assets
This companyUSD 136.26mMedianUSD 897.46kAverageUSD 31.52m

Websites

  • zarixa.plZarixa
    WordPressGoogle AnalyticsGoogle Tag ManagerNginx

Trademarks

The company holds 22 active trademarks registered with the Polish Patent Office. 7 marks have expired or were not registered. The first mark was filed in 2002.

MarkNumberClassesStatusProtected until
REDUZEK (word)Z.5745245Protected Sep 12, 2034
Pixara (word)Z.5650765Protected Jan 19, 2034
Zarixa (word)Z.5444035Protected Jun 24, 2032
Rivaxa (word)Z.5444025Protected Jun 24, 2032
TIKOZEK (word)Z.5125885Protected Apr 17, 2030
MarkProtected until
REDUZEK (word)Sep 12, 2034
Pixara (word)Jan 19, 2034
Zarixa (word)Jun 24, 2032
Rivaxa (word)Jun 24, 2032
TIKOZEK (word)Apr 17, 2030

Authorized Representatives

Krzysztof Dubiel age 46 – Attorney-in-fact (joint)
Justyna Rejmak age 47 – Management Board Member
Maciej Wieczorek age 57 – President of the Management Board
Małgorzata Stokrocka age 49 – Management Board Member

Manner of representation

President of the Management Board independently; two members of the management board jointly; one member of the management board jointly with a commercial proxy.

Supervisory board

Artur Wieczorek age 38 – Supervisory Board Member
Bogusław Marek Galewski age 65 – Supervisory Board Member
Krzysztof Kaczmarczyk age 50 – Supervisory Board Member
Robert Rzemiński age 55 – Supervisory Board Member
Urszula Wieczorek age 57 – Supervisory Board Member

Beneficial owners

Person

Subsidiaries

NameStake
73.2813%

Bank accounts

Registered as a VAT taxpayer on 2002-06-25.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

57 public aid cases recorded, with a total value of $144,110,691.

PurposeGross amount
Aid for research and development projects: industrial research
–
Aid for research and development projects: industrial research
–
Aid for research and development projects: fundamental research
–

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Biofarm sp. z o.o.
Przedsiębiorstwo Farmaceutyczne Lek-Am sp. z o.o.
Sandoz Polska sp. z o.o.
Chiesi Poland sp. z o.o.
Synoptis Pharma sp. z o.o.
Polfarmex S.A.
Solinea sp. z o.o.
SUN-Farm sp. z o.o.
Wörwag Pharma Operations sp. z o.o.
US Pharmacia sp. z o.o.

Change history

DateEvent
2025-10-10PKD change
2024-11-29Share capital increase
2024-08-06Share capital increase
2023-08-18Share capital increase
2022-10-17Share capital increase

FAQ

Last updated: 2026-09-22